Universal Technical Institute - UTI Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Universal Technical Institute in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" UTI shares.
View UTI analyst ratings or view top-rated stocks.

4 analysts have issued 1 year price targets for Universal Technical Institute's stock. Their UTI share price forecasts range from $10.00 to $14.00. On average, they anticipate the company's share price to reach $11.80 in the next year. This suggests a possible upside of 107.4% from the stock's current price.
View analysts price targets for UTI or view top-rated stocks among Wall Street analysts.

Universal Technical Institute's stock was trading at $7.82 at the start of the year. Since then, UTI stock has decreased by 27.2% and is now trading at $5.69.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 16th 2022.
View our UTI earnings forecast.

Universal Technical Institute, Inc. (NYSE:UTI) announced its quarterly earnings data on Wednesday, August, 3rd. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.23. The firm had revenue of $100.97 million for the quarter, compared to analyst estimates of $96.15 million. Universal Technical Institute had a trailing twelve-month return on equity of 31.52% and a net margin of 8.64%.

Universal Technical Institute updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $420.00 million-$420.00 million, compared to the consensus revenue estimate of $415.44 million.

7 employees have rated Universal Technical Institute Chief Executive Officer Jerome Grant on Glassdoor.com. Jerome Grant has an approval rating of 77% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Universal Technical Institute investors own include Dynavax Technologies (DVAX), General Electric (GE), Advanced Micro Devices (AMD), Ocular Therapeutix (OCUL), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Pfizer (PFE), AbbVie (ABBV), Ardelyx (ARDX) and A10 Networks (ATEN).

Universal Technical Institute trades on the New York Stock Exchange (NYSE) under the ticker symbol "UTI."

Shares of UTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of UTI stock can currently be purchased for approximately $5.69.

Universal Technical Institute (NYSE:UTI) has a market capitalization of $192.15 million and generates $335.08 million in revenue each year. The company earns $14.58 million in net income (profit) each year or $0.55 on an earnings per share basis.

The company employs 1,660 workers across the globe.

Universal Technical Institute's mailing address is 4225 EAST WINDROSE DRIVE SUITE 200, PHOENIX AZ, 85032. The official website for the company is www.uti.edu. The company can be reached via phone at (623) 445-9500, via email at investors@uti.edu, or via fax at 302-655-5049.